163 7 General Discussion 15. UNAIDS. New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price [Internet]. 2017 Sep [cited 2023 Oct 31]. Available from: https://www.unaids.org/en/resources/presscentre/ pressreleaseandstatementarchive/2017/september/20170921_TLD 16. Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019 Aug 29;381(9):803–15. 17. Seegert AB, Patsche CB, Sifna A, Gomes VF, Wejse C, Storgaard M, et al. Hypertension is associated with increased mortality in patients with tuberculosis in Guinea-Bissau. International Journal of Infectious Diseases. 2021;109:123–8. 18. Ali MK, Karanja S, Karama M. Factors associated with tuberculosis treatment outcomes among tuberculosis patients attending tuberculosis treatment centres in 2016-2017 in Mogadishu, Somalia. Pan Afr Med J. 2017;28:197. 19. Teferi MY, El-Khatib Z, Boltena MT, Andualem AT, Asamoah BO, Biru M, et al. Tuberculosis Treatment Outcome and Predictors in Africa: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health [Internet]. 2021 Jan [cited 2023 Aug 20];18(20):10678. Available from: https://www.mdpi.com/1660-4601/18/20/10678 20. Moreira J, Castro R, Lamas C, Ribeiro S, Grinsztejn B, Veloso VG. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil. Int J Infect Dis. 2018 Apr;69:11–9. 21. Boillat-Blanco N, Ramaiya KL, Mganga M, Minja LT, Bovet P, Schindler C, et al. Transient Hyperglycemia in Patients With Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms. J Infect Dis. 2016 Apr 1;213(7):1163–72. 22. Kornfeld H, Procter-Gray E, Kumpatla S, Kane K, Li W, Magee MJ, et al. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment. Diabetes Res Clin Pract. 2023 Feb;196:110242. 23. Salifu RS, Hlongwa M, Hlongwana K. Implementation of the WHO’s collaborative framework for the management of tuberculosis and diabetes: a scoping review. BMJ Open. 2021 Nov 17;11(11):e047342. 24. Basir M, Habib S, Zaidi S, Khowaja S, Hussain H, Ferrand R, et al. Operationalization of bi-directional screening for tuberculosis and diabetes in private sector healthcare clinics in Karachi, Pakistan. BMC HEALTH SERVICES RESEARCH. 2019 Mar 6;19. 25. Ncube RT, Dube SA, Machekera SM, Timire C, Zishiri C, Charambira K, et al. Feasibility and yield of screening for diabetes mellitus among tuberculosis patients in Harare, Zimbabwe. Public Health Action. 2019 Jun 21;9(2):72–7. 26. Shabangu K, Suleman F. Medicines availability at a Swaziland hospital and impact on patients. Afr J Prim Health Care Fam Med. 2015;7(1):e1–6. 27. World Health Organisation. Framework for collaborative action on tuberculosis and comorbidities [Internet]. Geneva: WHO; 2022 Oct [cited 2023 Aug 22]. Available from: https://www.who.int/ publications/i/item/9789240055056 28. World Health Organisation. Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: Implementation Guidance [Internet]. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/ item/9789240061682
RkJQdWJsaXNoZXIy MTk4NDMw